These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2083431)

  • 1. Review of oral skeletal muscle relaxants for the craniomandibular disorder (CMD) practitioner.
    Stanko JR
    Cranio; 1990 Jul; 8(3):234-43. PubMed ID: 2083431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Centrally acting oral skeletal muscle relaxants.
    Elenbaas JK
    Am J Hosp Pharm; 1980 Oct; 37(10):1313-23. PubMed ID: 6999895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle relaxants for pain management in rheumatoid arthritis.
    Richards BL; Whittle SL; Buchbinder R
    Cochrane Database Syst Rev; 2012 Jan; 1():CD008922. PubMed ID: 22258993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review.
    Chou R; Peterson K; Helfand M
    J Pain Symptom Manage; 2004 Aug; 28(2):140-75. PubMed ID: 15276195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone.
    Toth PP; Urtis J
    Clin Ther; 2004 Sep; 26(9):1355-67. PubMed ID: 15530999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Centrally acting skeletal muscle relaxants and associated drugs.
    Waldman HJ
    J Pain Symptom Manage; 1994 Oct; 9(7):434-41. PubMed ID: 7822882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Risk of Opioid Overdose With Concomitant Use of Prescription Opioids and Skeletal Muscle Relaxants.
    Khan NF; Bykov K; Barnett ML; Glynn RJ; Vine SM; Gagne JJ
    Neurology; 2022 Sep; 99(13):e1432-e1442. PubMed ID: 35835561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a low-dose regimen of cyclobenzaprine hydrochloride in acute skeletal muscle spasm: results of two placebo-controlled trials.
    Borenstein DG; Korn S
    Clin Ther; 2003 Apr; 25(4):1056-73. PubMed ID: 12809957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclobenzaprine in intractable pain syndromes with muscle spasm.
    Brown BR; Womble J
    JAMA; 1978 Sep; 240(11):1151-2. PubMed ID: 355663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind, placebo-controlled trial of carisoprodol 250-mg tablets in the treatment of acute lower-back spasm.
    Ralph L; Look M; Wheeler W; Sacks H
    Curr Med Res Opin; 2008 Feb; 24(2):551-8. PubMed ID: 18194591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Muscle Relaxants for the Treatment of Chronic Pain Associated with Cerebral Palsy.
    Peck J; Urits I; Crane J; McNally A; Noor N; Patel M; Berger AA; Cornett EM; Kassem H; Kaye AD; Viswanath O
    Psychopharmacol Bull; 2020 Oct; 50(4 Suppl 1):142-162. PubMed ID: 33633423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle relaxants--the current position in the treatment of spasticity in orthopedics.
    Zygmunt M; Sapa J
    Ortop Traumatol Rehabil; 2015; 17(4):423-30. PubMed ID: 26468180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new skeletal muscle relaxant (DS 103-282) compared to diazepam in the treatment of muscle spasm of local origin.
    Hennies OL
    J Int Med Res; 1981; 9(1):62-8. PubMed ID: 6451461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Relative Efficacy of Seven Skeletal Muscle Relaxants. An Analysis of Data From Randomized Studies.
    Abril L; Zamora C; Cordero M; Williams AR; Friedman BW
    J Emerg Med; 2022 Apr; 62(4):455-461. PubMed ID: 35067395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclobenzaprine in the treatment of acute muscle spasm: review of a decade of clinical experience.
    Katz WA; Dube J
    Clin Ther; 1988; 10(2):216-28. PubMed ID: 3078905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal muscle relaxants.
    See S; Ginzburg R
    Pharmacotherapy; 2008 Feb; 28(2):207-13. PubMed ID: 18225966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclobenzaprine hydrochloride effect on skeletal muscle spasm in the lumbar region and neck: two double-blind controlled clinical and laboratory studies.
    Basmajian JV
    Arch Phys Med Rehabil; 1978 Feb; 59(2):58-63. PubMed ID: 623512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of spastic syndromes].
    Hartmann-von Monakow K
    Bibl Psychiatr Neurol; 1969; 139():114-23. PubMed ID: 4257720
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacotherapy in Temporomandibular Disorders: A Review.
    Ouanounou A; Goldberg M; Haas DA
    J Can Dent Assoc; 2017 Jul; 83():h7. PubMed ID: 29513209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic management of spasticity following stroke.
    Gallichio JE
    Phys Ther; 2004 Oct; 84(10):973-81. PubMed ID: 15449979
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.